Amphastar Pharmaceuticals, Inc. (AMPH) stock
AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3033% below fair value
$28.87+0.27 (+0.94%)
Close on Nov 12, 2026Market cap $1.23BP/E 13.1Yield –
Amphastar Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Amphastar Pharmaceuticals's total debt was $613.00M at Sep 30, 2026. For fiscal 2025 it was $610.39M, up 1.4% from the year before. Over ten years it grew 31.0% a year on average. The highest annual figure on record is $610.39M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $610.39M | +1.4% |
| FY2024 | Dec 31, 2024 | $601.86M | +2.0% |
| FY2023 | Dec 31, 2023 | $590.02M | +677.5% |
| FY2022 | Dec 31, 2022 | $75.89M | -1.4% |
| FY2021 | Dec 31, 2021 | $76.98M | +65.7% |
| FY2020 | Dec 31, 2020 | $46.45M | -1.5% |
| FY2019 | Dec 31, 2019 | $47.14M | -6.1% |
| FY2018 | Dec 31, 2018 | $50.21M | +6.5% |
| FY2017 | Dec 31, 2017 | $47.16M | +25.0% |
| FY2016 | Dec 31, 2016 | $37.72M | -8.2% |
| FY2015 | Dec 31, 2015 | $41.10M | -6.0% |
| FY2014 | Dec 31, 2014 | $43.70M | +35.8% |
| FY2013 | Dec 31, 2013 | $32.17M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $613.00M | +0.6% |
| Q2 FY2026 | Jun 30, 2026 | $612.05M | +0.6% |
| Q1 FY2026 | Mar 31, 2026 | $611.47M | +1.2% |
| Q4 FY2025 | Dec 31, 2025 | $610.39M | +1.4% |
| Q3 FY2025 | Sep 30, 2025 | $609.51M | +2.1% |
| Q2 FY2025 | Jun 30, 2025 | $608.65M | +3.7% |
| Q1 FY2025 | Mar 31, 2025 | $604.08M | +1.6% |
| Q4 FY2024 | Dec 31, 2024 | $601.86M | +2.0% |
| Q3 FY2024 | Sep 30, 2024 | $596.70M | -8.7% |
| Q2 FY2024 | Jun 30, 2024 | $587.10M | +17.1% |
| Q1 FY2024 | Mar 31, 2024 | $594.43M | +692.2% |
| Q4 FY2023 | Dec 31, 2023 | $590.02M | +677.5% |
| Q3 FY2023 | Sep 30, 2023 | $653.70M | +763.6% |
| Q2 FY2023 | Jun 30, 2023 | $501.20M | +560.1% |
| Q1 FY2023 | Mar 31, 2023 | $75.04M | -1.9% |
| Q4 FY2022 | Dec 31, 2022 | $75.89M | -1.4% |
| Q3 FY2022 | Sep 30, 2022 | $75.69M | -2.7% |
| Q2 FY2022 | Jun 30, 2022 | $75.93M | +97.0% |
| Q1 FY2022 | Mar 31, 2022 | $76.51M | +71.9% |
| Q4 FY2021 | Dec 31, 2021 | $76.98M | +65.7% |
| Q3 FY2021 | Sep 30, 2021 | $77.81M | +72.6% |
| Q2 FY2021 | Jun 30, 2021 | $38.54M | -17.5% |
| Q1 FY2021 | Mar 31, 2021 | $44.51M | -7.0% |
| Q4 FY2020 | Dec 31, 2020 | $46.45M | -1.5% |
| Q3 FY2020 | Sep 30, 2020 | $45.07M | +0.0% |
| Q2 FY2020 | Jun 30, 2020 | $46.70M | -0.1% |
| Q1 FY2020 | Mar 31, 2020 | $47.87M | -1.4% |
| Q4 FY2019 | Dec 31, 2019 | $47.14M | -6.1% |
| Q3 FY2019 | Sep 30, 2019 | $45.05M | -12.0% |
| Q2 FY2019 | Jun 30, 2019 | $46.73M | -11.1% |
| Q1 FY2019 | Mar 31, 2019 | $48.56M | +6.1% |
| Q4 FY2018 | Dec 31, 2018 | $50.21M | +6.5% |
| Q3 FY2018 | Sep 30, 2018 | $51.20M | +5.7% |
| Q2 FY2018 | Jun 30, 2018 | $52.59M | +13.5% |
| Q1 FY2018 | Mar 31, 2018 | $45.77M | +25.7% |
| Q4 FY2017 | Dec 31, 2017 | $47.16M | +25.0% |
| Q3 FY2017 | Sep 30, 2017 | $48.44M | – |
| Q2 FY2017 | Jun 30, 2017 | $46.31M | – |
| Q1 FY2017 | Mar 31, 2017 | $36.41M | – |
| Q4 FY2016 | Dec 31, 2016 | $37.72M | – |
See a number that looks wrong?